David E. Blask
Laboratory of Experimental Neuroendocrinology/Oncology
Bassett Research Institute
Cooperstown
New York 13326-1394
USA
Name/email consistency: high
- Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Blask, D.E., Sauer, L.A., Dauchy, R.T. Curr. Top. Med. Chem (2002)
- New actions of melatonin on tumor metabolism and growth. Blask, D.E., Sauer, L.A., Dauchy, R., Holowachuk, E.W., Ruhoff, M.S. Biol. Signals. Recept (1999)
- Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Blask, D.E., Sauer, L.A., Dauchy, R.T., Holowachuk, E.W., Ruhoff, M.S., Kopff, H.S. Cancer Res. (1999)